Interaction of antibacterial compounds with RND efflux pumps in Pseudomonas aeruginosa

Frontiers in Microbiology

Volumn 6, Issue JUL, 2015, Pages

  Dreier, Jürg ^a   Ruggerone, Paolo ^b  

^a BASILEA PHARMACEUTICA INTERNATIONAL LTD   (Switzerland)

^b UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Antibiotic agents; Bacteria; Efflux; Efflux pump inhibitors; Multi drug resistance; Pseudomonas aeruginsoa; RND; Substrate recognition

Indexed keywords

CEPHALOSPORIN; CERULENIN; CHLORAMPHENICOL; MACROLIDE; NOVOBIOCIN; QUINOLONE DERIVATIVE; TETRACYCLINE; THIOLACTOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; CELL TRANSPORT; ESCHERICHIA COLI; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROPHOBICITY; IMMUNOBLOTTING; LIPOPHILICITY; MINIMUM INHIBITORY CONCENTRATION; PERMEABILITY; PSEUDOMONAS AERUGINOSA; RESISTANCE NODULATION CELL DIVISION EFFLUX PUMP; REVIEW; SALMONELLA ENTERICA; TRANSPORT ASSAY;

PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

EID: 84938894017     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2015.00660     Document Type: Review

References (265)

1. Aires, J. R., and Nikaido, H. (2005). Aminoglycosides are captured from both periplasm and cytoplasm by the AcrD multidrug effux transporter of Escherichia coli. J. Bacteriol. 187, 1923-1929. doi: 10.1128/JB.187.6.1923-1929.2005.
2. Akama, H., Kanemaki, M., Yoshimura, M., Tsukihara, T., Kashiwagi, T., Yoneyama, H., et al. (2004a). Crystal structure of the drug discharge outer membrane protein, OprM, of Pseudomonas aeruginosa: dual modes of membrane anchoring and occluded cavity end. J. Biol. Chem. 279, 52816-52819. doi: 10.1074/jbc.C400445200.
3. Akama, H., Matsuura, T., Kashiwagi, S., Yoneyama, H., Narita, S.-I., Tsukihara, T., et al. (2004b). Crystal structure of the membrane fusion protein, MexA, of the multidrug transporter in Pseudomonas aeruginosa. J. Biol. Chem. 279, 25939-25942. doi: 10.1074/jbc.C400164200.
4. Amin, I. M., Richmond, G. E., Sen, P., Koh, T. H., Piddock, L. J., and Chua, K. L. (2013). A method for generating marker-less gene deletions in multidrug-resistant Acinetobacter baumannii. BMC Microbiol. 13:158. doi: 10.1186/1471-2180-13-158.
5. Angus, B. L., Carey, A. M., Caron, D. A., Kropinski, A. M., and Hancock, R. E. (1982). Outer membrane permeability in Pseudomonas aeruginosa: comparison of a wild-type with an antibiotic-supersusceptible mutant. Antimicrob. Agents Chemother. 21, 299-309. doi: 10.1128/AAC.21.2.299.
6. Baum, E. Z., Crespo-Carbone, S. M., Morrow, B. J., Davies, T. A., Foleno, B. D., He, W., et al. (2009). Effect of MexXY overexpression on ceftobiprole susceptibility in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 53, 2785-2790. doi: 10.1128/AAC.00018-09.
7. Bavro, V. N., Pietras, Z., Furnham, N., Pérez-Cano, L., Fernández-Recio, J., Pei, X. Y., et al. (2008). Assembly and channel opening in a bacterial drug effux machine. Mol. Cell. 30, 114-121. doi: 10.1016/j.molcel.2008.02.015.
8. Biarnés, X., Bongarzone, S., Vargiu, A. V., Carloni, P., and Ruggerone, P. (2011). Molecular motions in drug design: the coming age of the metadynamics method. J. Comput. Aided Mol. Des. 25, 395-402. doi: 10.1007/s10822-011-9415-3.
9. Blair, J. M., Bavro, V. N., Ricci, V., Modi, N., Cacciotto, P., Kleinekathfer, U., et al. (2015a). AcrB drug-binding pocket substitution confers clinically relevant resistance and altered substrate specificity. Proc. Natl. Acad. Sci. U.S.A. 112, 3511-3516. doi: 10.1073/pnas.1419939112.
10. Blair, J. M. A., Webber, M. A., Baylay, A. J., Ogbolu, D. O., and Piddock, L. J. V. (2015b). Molecular mechanisms of antibiotic resistance. Nat. Rev. Microbiol. 13, 42-51. doi: 10.1038/nrmicro3380.
11. Blair, J. M., Richmond, G. E., and Piddock, L. J. (2014). Multidrug effux pumps in Gram-negative bacteria and their role in antibiotic resistance. Fut. Microbiol. 9, 1165-1177. doi: 10.2217/fmb.14.66.
12. Bohnert, J. A., Karamian, B., and Nikaido, H. (2010). Optimized Nile Red effux assay of AcrAB-TolC multidrug effux system shows competition between substrates. Antimicrob. Agents Chemother. 54, 3770-3775. doi: 10.1128/AAC.00620-10.
13. Bohnert, J. A., Schuster, S., Seeger, M. A., Fähnrich, E., Pos, K. M., and Kern, W. V. (2008). Site-directed mutagenesis reveals putative substrate binding residues in the Escherichia coli RND effux pump AcrB. J. Bacteriol. 190, 8225-8229. doi: 10.1128/JB.00912-08.
14. Bohnert, J. A., Schuster, S., Szymaniak-Vits, M., and Kern, W. V. (2011a). Determination of real-time effux phenotypes in Escherichia coli AcrB binding pocket phenylalanine mutants using a 1,2'-dinaphthylamine effux assay. PLoS ONE 6:e21196. doi: 10.1371/journal.pone.0021196.
15. Bohnert, J. A., Szymaniak-Vits, M., Schuster, S., and Kern, W. V. (2011b). Effux inhibition by selective serotonin reuptake inhibitors in Escherichia coli. J. Antimicrob. Chemother. 66, 2057-2060. doi: 10.1093/jac/dkr258.
16. Borges-Walmsley, M. I., Mckeegan, K. S., and Walmsley, A. R. (2003). Structure and function of effux pumps that confer resistance to drugs. Biochem. J. 376, 313-338. doi: 10.1042/BJ20020957 .
17. Brown, D. G., May-Dracka, T. L., Gagnon, M. M., and Tommasi, R. (2014). Trends and exceptions of physical properties on antibacterial activity for Gram-positive and Gram-negative pathogens. J. Med. Chem. 57, 10144-10161. doi: 10.1021/jm501552x.
18. Butler, M. J., Bergeron, A., Soostmeyer, G., Zimny, T., and Malek, L. T. (1993). Cloning and characterisation of an aminopeptidase P-encoding gene from Streptomyces lividans. Gene 123, 115-119. doi: 10.1016/0378-1119(93)90549-I.
19. Cai, H., Rose, K., Liang, L. H., Dunham, S., and Stover, C. (2009). Development of a liquid chromatography/mass spectrometry-based drug accumulation assay in Pseudomonas aeruginosa. Anal. Biochem. 385, 321-325. doi: 10.1016/j.ab.2008.10.041.
20. Caiazza, N. C., Shanks, R. M., and O'toole, G. A. (2005). Rhamnolipids modulate swarming motility patterns of Pseudomonas aeruginosa. J. Bacteriol. 187, 7351-7361. doi: 10.1128/JB.187.21.7351-7361.2005.
21. Castanheira, M., Deshpande, L. M., Costello, A., Davies, T. A., and Jones, R. N. (2014). Epidemiology and carbapenem resistance mechanisms of carbapenem-non-susceptible Pseudomonas aeruginosa collected during 2009-11 in 14 European and Mediterranean countries. J. Antimicrob. Chemother. 69, 1804-1814. doi: 10.1093/jac/dku048.
22. CDC. (2013). US Department Health and Human Services. Centers for Disease Control and Prevention. Antibiotic Resistance Threats in the United States, 2013. Available at: http://www.cdc.gov/drugresistance/pdf/arthreats-2013-508.pdf.
23. Chen, J., Morita, Y., Huda, M. N., Kuroda, T., Mizushima, T., and Tsuchiya, T. (2002). VmrA a member of a novel class of Na+-coupled multidrug effux pumps from Vibrio parahaemolyticus. J. Bacteriol. 184, 572-576. doi: 10.1128/JB.184.2.572-576.2002.
24. Chipot, C. (2008). Free energy calculations applied to membrane proteins. Methods Mol. Biol. 443, 121-144. doi: 10.1007/978-1-59745-177-2_7.
25. Chollet, R., Chevalier, J., Bryskier, A., and Pages, J. M. (2004). The AcrAB-TolC pump is involved in macrolide resistance but not in telithromycin effux in Enterobacter aerogenes and Escherichia coli. Antimicrob. Agents Chemother. 48, 3621-3624. doi: 10.1128/AAC.48.9.3621-3624.2004.
26. Chopra, I. (2002). New developments in tetracycline antibiotics: glycylcyclines and tetracycline effux pump inhibitors. Drug Resist. Update 5, 119-125. doi: 10.1016/S1368-7646(02)00051-1.
27. Chopra, I., and Roberts, M. (2001). Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol. Mol. Biol. Rev. 65, 232-260. doi: 10.1128/MMBR.65.2.232-260.2001.
28. Collu, F., and Cascella, M. (2013). Multidrug resistance and effux pumps: insights from molecular dynamics simulations. Curr. Top. Med. Chem. 13, 3165-3183. doi: 10.2174/15680266113136660224.
29. Collu, F., Ceccarelli, M., and Ruggerone, P. (2012a). Exploring binding properties of agonists interacting with a d-opioid receptor. PLoS ONE 7:e52633. doi: 10.1371/journal.pone.0052633.
30. Collu, F., Vargiu, A. V., Dreier, J., Cascella, M., and Ruggerone, P. (2012b). Recognition of imipenem and meropenem by the Rnd-transporter MexB studied by computer simulations. J. Am. Chem. Soc. 134, 19146-19158. doi: 10.1021/ja307803m.
31. Cowan, S. W., Schirmer, T., Rummel, G., Steiert, M., Ghosh, R., Pauptit, R. A., et al. (1992). Crystal structures explain functional properties of two E. coli porins. Nature 358, 727-733. doi: 10.1038/358727a0.
32. Coyne, S., Rosenfeld, N., Lambert, T., Courvalin, P., and Perichon, B. (2010). Overexpression of resistance-nodulation-cell division pump AdeFGH confers multidrug resistance in Acinetobacter baumannii. Antimicrob. Agents Chemother. 54, 4389-4393. doi: 10.1128/AAC.00155-10.
33. Dal Peraro, M., Ruggerone, P., Raugei, S., Gervasio, F. L., and Carloni, P. (2007). Investigating biological systems using first principles Car-Parrinello molecular dynamics simulations. Curr. Opin. Struc. Biol. 17, 149-156. doi: 10.1016/j.sbi.2007.03.018.
34. Damier-Piolle, L., Magnet, S., Bremont, S., Lambert, T., and Courvalin, P. (2008). AdeIJK, a resistance-nodulation-cell division pump effuxing multiple antibiotics in Acinetobacter baumannii. Antimicrob. Agents Chemother. 52, 557-562. doi: 10.1128/AAC.00732-07.
35. Davin-Regli, A., Bolla, J. M., James, C. E., Lavigne, J. P., Chevalier, J., Garnotel, E., et al. (2008). Membrane permeability and regulation of drug "influx and effux" in enterobacterial pathogens. Curr. Drug Targets 9, 750-759. doi: 10.2174/138945008785747824.
36. Dean, C. R., Visalli, M. A., Projan, S. J., Sum, P. E., and Bradford, P. A. (2003). Effux-mediated resistance to tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1. Antimicrob. Agents Chemother. 47, 972-978. doi: 10.1128/AAC.47.3.972-978.2003.
37. Delcour, A. H. (2009). Outer membrane permeability and antibiotic resistance. Biochim. Biophys. Acta 1794, 808-816. doi: 10.1016/j.bbapap.2008.11.005.
38. Delmar, J. A., Su, C. C., and Yu, E. W. (2014). Bacterial multidrug effux transporters. Annu. Rev. Biophys. 43, 93-117. doi: 10.1146/annurev-biophys-051013-022855.
39. Denys, G. A., and Relich, R. F. (2014). Antibiotic resistance in nosocomial respiratory infections. Clin. Lab. Med. 34, 257-270. doi: 10.1016/j.cll.2014.02.004.
40. de Vries, S. J., and Zacharias, M. (2012). Attract-Em: a new method for the computational assembly of large molecular machines using cryo-EM maps. PLoS ONE 7:e49733. doi: 10.1371/journal.pone.0049733.
41. Deziel, E., Lepine, F., Milot, S., and Villemur, R. (2003). rhlA is required for the production of a novel biosurfactant promoting swarming motility in Pseudomonas aeruginosa: 3-(3-hydroxyalkanoyloxy)alkanoic acids (HAAs), the precursors of rhamnolipids. Microbiology 149, 2005-2013. doi: 10.1099/mic.0.26154-0.
42. Dreier, J. (2007). "Active Drug Effux in Bacteria," in: Enzyme-Mediated Resistance to Antibiotics: Mechanisms, Dissemination, and Prospects for Inhibition, First Edn, ed. R. A. T. M. E. Bonomo (Washington, DC: ASM Press). doi: 10.1128/9781555815615.ch15.
43. Du, D., Van Veen, H. W., and Luisi, B. F. (2015). Assembly and operation of bacterial tripartite multidrug effux pumps. Trends Microbiol. 23, 311-319. doi: 10.1016/j.tim.2015.01.010.
44. Du, D., Wang, Z., James, N. R., Voss, J. E., Klimont, E., Ohene-Agyei, T., et al. (2014). Structure of the AcrAB-TolC multidrug effux pump. Nature 509, 512-515. doi: 10.1038/nature13205.
45. Dunham, S. A., Mcpherson, C. J., and Miller, A. A. (2010). The relative contribution of effux and target gene mutations to fluoroquinolone resistance in recent clinical isolates of Pseudomonas aeruginosa. Eur. J. Clin. Microbiol. Infect. Dis. 29, 279-288. doi: 10.1007/s10096-009-0852-z.
46. ECDC. (2015). European Centre for Disease Prevention and Control. Annual Epidemiological Report 2014 Antimicrobial Resistance and Healthcare-Associated Infections, Stockholm.
47. Eda, S., Maseda, H., and Nakae, T. (2003). An elegant means of self-protection in gram-negative bacteria by recognizing and extruding xenobiotics from the periplasmic space. J. Biol. Chem. 278, 2085-2088. doi: 10.1074/jbc.C200661200.
48. Eguchi, K., Ueda, Y., Kanazawa, K., Sunagawa, M., and Gotoh, N. (2007). The mode of action of 2-(thiazol-2-ylthio)-1beta-methylcarbapenems against Pseudomonas aeruginosa: the impact of outer membrane permeability and the contribution of MexAB-OprM effux system. J. Antibiot. 60, 129-135. doi: 10.1038/ja.2007.12.
49. Eicher, T., Brandstatter, L., and Pos, K. M. (2009). Structural and functional aspects of the multidrug effux pump AcrB. Biol. Chem. 390, 693-699. doi: 10.1515/BC.2009.090.
50. Eicher, T., Cha, H. J., Seeger, M. A., Brandstatter, L., El-Delik, J., Bohnert, J. A., et al. (2012). Transport of drugs by the multidrug transporter AcrB involves an access and a deep binding pocket that are separated by a switch-loop. Proc. Natl. Acad. Sci. U.S.A. 109, 5687-5692. doi: 10.1073/pnas.1114944109.
51. Eicher, T., Seeger, M. A., Anselmi, C., Zhou, W., Brandstatter, L., Verrey, F., et al. (2014). Coupling of remote alternating-access transport mechanisms for protons and substrates in the multidrug effux pump AcrB. Elife 19, 3. doi: 10.7554/eLife.03145.
52. Elkins, C. A., and Nikaido, H. (2002). Substrate specificity of the RND-type multidrug effux pumps AcrB and AcrD of Escherichia coli is determined predominantly by two large periplasmic loops. J. Bacteriol. 184, 6490-6498. doi: 10.1128/JB.184.23.6490-6499.2002.
53. Fernandez, L., and Hancock, R. E. (2012). Adaptive and mutational resistance: role of porins and effux pumps in drug resistance. Clin. Microbiol. Rev. 25, 661-681. doi: 10.1128/CMR.00043-12.
54. Ferrandez, Y., Monlezun, L., Phan, G., Benabdelhak, H., Benas, P., Ulryck, N., et al. (2012). Stoichiometry of the MexA-OprM binding, as investigated by blue native gel electrophoresis. Electrophoresis 33, 1282-1287. doi: 10.1002/elps.201100541.
55. Ferreira, M. M. C., and Kiralj, R. (2004). QSAR study of β-lactam antibiotic effux by the multidrug resistance pump AcrB. J. Chemometr. 18, 242-252. doi: 10.1002/cem.867.
56. Fieldler, F., and Hinz, H. (1994). No intermediate channelling in stepwise hydrolysis of fluorescein di-beta-D-galactoside by beta-galactosidase. Eur. J. Biochem. 222, 75-81. doi: 10.1111/j.1432-1033.1994.tb18843.x.
57. Fischer, N., and Kandt, C. (2011). Three ways in, one way out: water dynamics in the trans-membrane domains of the inner membrane translocase AcrB. Proteins 79, 2871-2885. doi: 10.1002/prot.23122.
58. Fischer, N., and Kandt, C. (2012). Porter domain opening and closing motions in the multi-drug effux transporter AcrB. Biochim. Biophys. Acta 1828, 632-641. doi: 10.1016/j.bbamem.2012.10.016.
59. Fischer, N., Raunest, M., Schmidt, T. H., Koch, D. C., and Kandt, C. (2014). Effux pump-mediated antibiotics resistance: insights from computational structural biology. Interdiscip. Sci. 6, 1-12. doi: 10.1007/s12539-014-0191-3.
60. Fukuda, H., Hosaka, M., Hirai, K., and Iyobe, S. (1990). New norfloxacin resistance gene in Pseudomonas aeruginosa Pao. Antimicrob. Agents Chemother. 34, 1757-1761. doi: 10.1128/AAC.34.9.1757 .
61. Fukuda, H., Hosaka, M., Iyobe, S., Gotoh, N., Nishino, T., and Hirai, K. (1995). nfxC-type quinolone resistance in a clinical isolate of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 39, 790-792. doi: 10.1128/AAC.39.3.790.
62. Garvey, M. I., and Piddock, L. J. (2008). The effux pump inhibitor reserpine selects multidrug-resistant Streptococcus pneumoniae strains that overexpress the ABC transporters PatA and PatB. Antimicrob. Agents Chemother. 52, 1677-1685. doi: 10.1128/AAC.01644-07.
63. Germ, M., Yoshihara, E., Yoneyama, H., and Nakae, T. (1999). Interplay between the effux pump and the outer membrane permeability barrier in fluorescent dye accumulation in Pseudomonas aeruginosa. Biochem. Biophys. Res. Commun. 261, 452-455. doi: 10.1006/bbrc.1999.1045.
64. Giske, C. G., Boren, C., Wretlind, B., and Kronvall, G. (2005). Meropenem susceptibility breakpoint for Pseudomonas aeruginosa strains hyperproducing mexB mRNA. Clin. Microbiol. Infect. 11, 662-669. doi: 10.1111/j.1469-0691.2005.01182.x.
65. Gonzalez, R. J., and Tarloff, J. B. (2001). Evaluation of hepatic subcellular fractions for Alamar blue and MTT reductase activity. Toxicol. In Vitro 15, 257-259. doi: 10.1016/S0887-2333(01)00014-5.
66. Greenspan, P., and Fowler, S. D. (1985). Spectrofluorometric studies of the lipid probe, nile red. J. Lipid Res. 26, 781-789.
67. Griffith, D. C., Corcoran, E., Lofland, D., Lee, A., Cho, D., Lomovskaya, O., et al. (2006). Pharmacodynamics of levofloxacin against Pseudomonas aeruginosa with reduced susceptibility due to different effux pumps: do elevated MICs always predict reduced in vivo efficacy? Antimicrob. Agents Chemother. 50, 1628-1632. doi: 10.1128/AAC.50.5.1628-1632.2006.
68. Grkovic, S., Brown, M. H., and Skurray, R. A. (2002). Regulation of bacterial drug export systems. Microbiol. Mol. Biol. Rev. 66, 671-701. doi: 10.1128/MMBR.66.4.671-701.2002.
69. Hancock, R. E. (1997). The bacterial outer membrane as a drug barrier. Trends Microbiol. 5, 37-42. doi: 10.1016/S0966-842X(97)81773-8 .
70. Hayashi, K., Fukushima, A., Hayashi-Nishino, M., and Nishino, K. (2014). Effect of methylglyoxal on multidrug-resistant Pseudomonas aeruginosa. Front. Microbiol. 5:180. doi: 10.3389/fmicb.2014.00180.
71. Hidron, A. I., Edwards, J. R., Patel, J., Horan, T. C., Sievert, D. M., Pollock, D. A., et al. (2008). NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect. Control. Hosp. Epidemiol. 29, 996-1011. doi: 10.1086/591861.
72. Hinchliffe, P., Symmons, M. F., Hughes, C., and Koronakis, V. (2013). Structure and operation of bacterial tripartite pumps. Annu. Rev. Microbiol. 67, 221-242. doi: 10.1146/annurev-micro-092412-155718.
73. Hirata, T., Saito, A., Nishino, K., Tamura, N., and Yamaguchi, A. (2004). Effects of effux transporter genes on susceptibility of Escherichia coli to tigecycline (GAR-936). Antimicrob. Agents Chemother. 48, 2179-2184. doi: 10.1128/AAC.48.6.2179-2184.2004.
74. Hocquet, D., Nordmann, P., El Garch, F., Cabanne, L., and Plesiat, P. (2006). Involvement of the MexXY-OprM effux system in emergence of cefepime resistance in clinical strains of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 50, 1347-1351. doi: 10.1128/AAC.50.4.1347-1351.2006.
75. Humphrey, W., Dalke, A., and Schulten, K. (1996). Vmd: visual molecular dynamics. J. Mol. Graph. 14, 33-38. doi: 10.1016/0263-7855(96)00018-5.
76. Husain, F., and Nikaido, H. (2010). Substrate path in the AcrB multidrug effux pump of Escherichia coli. Mol. Microbiol. 78, 320-330. doi: 10.1111/j.1365-2958.2010.07330.x.
77. Iino, R., Hayama, K., Amezawa, H., Sakakihara, S., Kim, S. H., Matsumono, Y., et al. (2012a). A single-cell drug effux assay in bacteria by using a directly accessible femtoliter droplet array. Lab. Chip. 12, 3923-3929. doi: 10.1039/c2lc40394c.
78. Iino, R., Nishino, K., Noji, H., Yamaguchi, A., and Matsumoto, Y. (2012b). A microfluidic device for simple and rapid evaluation of multidrug effux pump inhibitors. Front. Microbiol. 3:40. doi: 10.3389/fmicb.2012.00040 .
79. Iino, R., Matsumoto, Y., Nishino, K., Yamaguchi, A., and Noji, H. (2013). Design of a large-scale femtoliter droplet array for single-cell analysis of drug-tolerant and drug-resistant bacteria. Front. Microbiol. 4:300. doi: 10.3389/fmicb.2013.00300.
80. Jones, R. N., Stilwell, M. G., Rhomberg, P. R., and Sader, H. S. (2009). Antipseudomonal activity of piperacillin/tazobactam: more than a decade of experience from the SENTRY Antimicrobial Surveillance Program (1997-2007). Diagn. Microbiol. Infect. Dis. 65, 331-334. doi: 10.1016/j.diagmicrobio.2009.06.022.
81. Kamal, M. Z., Ali, J., and Rao, N. M. (2013). Binding of bis-ANS to Bacillus subtilis lipase: a combined computational and experimental investigation. Biochim. Biophys. Acta 1834, 1501-1509. doi: 10.1016/j.bbapap.2013.04.021.
82. Kamerlin, S. C., Vicatos, S., Dryga, A., and Warshel, A. (2011). Coarse-grained (multiscale) simulations in studies of biophysical and chemical systems. Annu. Rev. Phys. Chem. 62, 41-64. doi: 10.1146/annurev-physchem-032210-103335.
83. Kamio, Y., and Nikaido, H. (1976). Outer membrane of Salmonella typhimurium: accessibility of phospholipid head groups to phospholipase c and cyanogen bromide activated dextran in the external medium. Biochemistry 15, 2561-2570. doi: 10.1021/bi00657a012.
84. Karplus, M. (2014). Development of multiscale models for complex chemical systems: from H+H(2) to biomolecules (Nobel Lecture). Angew. Chem. Int. Ed. Engl. 53, 9992-10005. doi: 10.1002/anie.201403924.
85. Kim, J. S., Jeong, H., Song, S., Kim, H.-Y., Lee, K., Hyun, J., et al. (2015). Structure of the tripartite multidrug effux pump acrab-TolC suggests an alternative assembly mode. Mol. Cells 38, 180-186. doi: 10.14348/molcells.2015.2277.
86. Kinana, A. D., Vargiu, A. V., and Nikaido, H. (2013). Some ligands enhance the effux of other ligands by the Escherichia coli multidrug pump AcrB. Biochemistry 52, 8342-8351. doi: 10.1021/bi401303v.
87. Kobayashi, N., Tamura, N., Van Veen, H. W., Yamaguchi, A., and Murakami, S. (2014). beta-Lactam selectivity of multidrug transporters AcrB and AcrD resides in the proximal binding pocket. J. Biol. Chem. 289, 10680-10690. doi: 10.1074/jbc.M114.547794.
88. Kohler, T., Kok, M., Michea-Hamzehpour, M., Plesiat, P., Gotoh, N., Nishino, T., et al. (1996). Multidrug effux in intrinsic resistance to trimethoprim and sulfamethoxazole in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 40, 2288-2290.
89. Kohler, T., Michea-Hamzehpour, M., Plesiat, P., Kahr, A. L., and Pechere, J. C. (1997). Differential selection of multidrug effux systems by quinolones in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 41, 2540-2543.
90. Kollman, P. A., Massova, I., Reyes, C., Kuhn, B., Huo, S., Chong, L., et al. (2000). Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. Acc. Chem. Res. 33, 889-897. doi: 10.1021/ar000033j.
91. Koronakis, V., Eswaran, J., and Hughes, C. (2004). Structure and function of TolC: the bacterial exit duct for proteins and drugs. Annu. Rev. Biochem. 73, 467-489. doi: 10.1146/annurev.biochem.73.011303.074104.
92. Koronakis, V., Sharff, A., Koronakis, E., Luisi, B., and Hughes, C. (2000). Crystal structure of the bacterial membrane protein TolC central to multidrug effux and protein export. Nature 405, 914-919. doi: 10.1038/35016007.
93. Kriengkauykiat, J., Porter, E., Lomovskaya, O., and Wong-Beringer, A. (2005). Use of an effux pump inhibitor to determine the prevalence of effux pump-mediated fluoroquinolone resistance and multidrug resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 49, 565-570. doi: 10.1128/AAC.49.2.565-570.2005.
94. Krishnamoorthy, G., Tikhonova, E. B., Dhamdhere, G., and Zgurskaya, H. I. (2013). On the role of TolC in multidrug effux: the function and assembly of AcrAB-TolC tolerate significant depletion of intracellular TolC protein. Mol. Microbiol. 87, 982-997. doi: 10.1111/mmi.12143.
95. Krishnamoorthy, G., Tikhonova, E. B., and Zgurskaya, H. I. (2008). Fitting periplasmic membrane fusion proteins to inner membrane transporters: mutations that enable Escherichia coli AcrA to function with Pseudomonas aeruginosa MexB. J. Bacteriol. 190, 691-698. doi: 10.1128/JB.01276-07 .
96. Kumar, A., Chua, K. L., and Schweizer, H. P. (2006). Method for regulated expression of single-copy effux pump genes in a surrogate Pseudomonas aeruginosa strain: identification of the BpeEF-OprC chloramphenicol and trimethoprim effux pump of Burkholderia pseudomallei 1026b. Antimicrob. Agents Chemother. 50, 3460-3463. doi: 10.1128/AAC.00440-06.
97. Kumar, A., and Schweizer, H. P. (2005). Bacterial resistance to antibiotics: active effux and reduced uptake. Adv. Drug Deliv. Rev. 57, 1486-1513. doi: 10.1016/j.addr.2005.04.004.
98. Laio, A., and Gervasio, F. L. (2008). Metadynamics: a method to simulate rare events and reconstruct the free energy in biophysics, chemistry and material science. Rep. Prog. Phys. 71, 126601. doi: 10.1088/0034-4885/71/12/126601.
99. Laio, A., Rodriguez-Fortea, A., Gervasio, F. L., Ceccarelli, M., and Parrinello, M. (2005). Assessing the accuracy of metadynamics. J. Phys. Chem. B 109, 6714-6721. doi: 10.1021/jp045424k.
100. Lamers, R. P., Cavallari, J. F., and Burrows, L. L. (2013). The effux inhibitor phenylalanine-arginine beta-naphthylamide (PabetaN) permeabilizes the outer membrane of gram-negative bacteria. PLoS ONE 8:e60666. doi: 10.1371/journal.pone.0060666.
101. Lau, C. H., Hughes, D., and Poole, K. (2014). MexY-promoted aminoglycoside resistance in Pseudomonas aeruginosa: involvment of a putative proximal binding pocket in aminoglycoside recognition. MBio 5:e01068. doi: 10.1128/mBio.01068-4.
102. LePecq, J. B., and Paoletti, C. (1967). A fluorescent complex between ethidium bromide and nucleic acids. Physical-chemical characterization. J. Mol. Biol. 27, 87-106. doi: 10.1016/0022-2836(67)90353-1.
103. Levy, S. B. (1992). Active effux mechanisms for antimicrobial resistance. Antimicrob. Agents Chemother. 36, 695-703. doi: 10.1128/AAC.36.4.695.
104. Li, X. Z., Ma, D., Livermore, D. M., and Nikaido, H. (1994). Role of effux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: active effux as a contributing factor to beta-lactam resistance. Antimicrob. Agents Chemother. 38, 1742-1752. doi: 10.1128/AAC.38.8.1742 .
105. Li, X. Z., Nikaido, H., and Poole, K. (1995). Role of mexA-mexB-oprM in antibiotic effux in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 39, 1948-1953. doi: 10.1128/AAC.39.9.1948.
106. Li, X. Z., Plesiat, P., and Nikaido, H. (2015). The challenge of effux-mediated antibiotic resistance in Gram-negative bacteria. Clin. Microbiol. Rev. 28, 337-418. doi: 10.1128/CMR.00117-14.
107. Li, Y., Mima, T., Komori, Y., Morita, Y., Kuroda, T., Mizushima, T., et al. (2003). A new member of the tripartite multidrug effux pumps, MexVW-OprM, in Pseudomonas aeruginosa. J. Antimicrob. Chemother. 52, 572-575. doi: 10.1093/jac/dkg390.
108. Lister, P. D., Wolter, D. J., and Hanson, N. D. (2009). Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin. Microbiol. Rev. 22, 582-610. doi: 10.1128/CMR.00040-09.
109. Livermore, D. M. (2009). Has the era of untreatable infections arrived? J. Antimicrob. Chemother. 64(Suppl. 1), i29-i36. doi: 10.1093/jac/dkp255.
110. Loh, B., Grant, C., and Hancock, R. E. (1984). Use of the fluorescent probe 1-N-phenylnaphthylamine to study the interactions of aminoglycoside antibiotics with the outer membrane of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 26, 546-551. doi: 10.1128/AAC.26.4.546.
111. Lomovskaya, O., and Bostian, K. A. (2006). Practical applications and feasibility of effux pump inhibitors in the clinic-a vision for applied use. Biochem. Pharmacol. 71, 910-918. doi: 10.1016/j.bcp.2005.12.008.
112. Lomovskaya, O., Lee, A., Hoshino, K., Ishida, H., Mistry, A., Warren, M. S., et al. (1999). Use of a genetic approach to evaluate the consequences of inhibition of effux pumps in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 43, 1340-1346.
113. Lomovskaya, O., Warren, M. S., Lee, A., Galazzo, J., Fronko, R., Lee, M., et al. (2001). Identification and characterization of inhibitors of multidrug resistance effux pumps in Pseudomonas aeruginosa: novel agents for combination therapy. Antimicrob. Agents Chemother. 45, 105-116. doi: 10.1128/AAC.45.1.105-116.2001 .
114. Loontiens, F. G., Regenfuss, P., Zechel, A., Dumortier, L., and Clegg, R. M. (1990). Binding characteristics of Hoechst 33258 with calf thymus DNA, poly[d(A-T)], and d(CCGGAATTCCGG): multiple stoichiometries and determination of tight binding with a wide spectrum of site affinities. Biochemistry 29, 9029-9039. doi: 10.1021/bi00490a021.
115. Ma, D., Cook, D. N., Alberti, M., Pon, N. G., Nikaido, H., and Hearst, J. E. (1993). Molecular cloning and characterization of acrA and acrE genes of Escherichia coli. J. Bacteriol. 175, 6299-6313.
116. Magnet, S., Courvalin, P., and Lambert, T. (2001). Resistance-nodulation-cell division-type effux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454. Antimicrob. Agents Chemother. 45, 3375-3380. doi: 10.1128/AAC.45.12.3375-3380.2001.
117. Mahamoud, A., Chevalier, J., Alibert-Franco, S., Kern, W. V., and Pages, J. M. (2007). Antibiotic effux pumps in Gram-negative bacteria: the inhibitor response strategy. J. Antimicrob. Chemother. 59, 1223-1229. doi: 10.1093/jac/dkl493.
118. Mao, W., Warren, M. S., Black, D. S., Satou, T., Murata, T., Nishino, T., et al. (2002). On the mechanism of substrate specificity by resistance nodulation division (RND)-type multidrug resistance pumps: the large periplasmic loops of MexD from Pseudomonas aeruginosa are involved in substrate recognition. Mol. Microbiol. 46, 889-901. doi: 10.1046/j.1365-2958.2002.03223.x.
119. Mao, W., Warren, M. S., Lee, A., Mistry, A., and Lomovskaya, O. (2001). MexXY-OprM effux pump is required for antagonism of aminoglycosides by divalent cations in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 45, 2001-2007. doi: 10.1128/AAC.45.7.2001-2007.2001.
120. Marks, N., Suhar, A., and Benuck, M. (1981). Peptide processing in the central nervous system. Adv. Biochem. Psychopharmacol. 28, 49-60.
121. Markwick, P. R., and McCammon, J. A. (2011). Studying functional dynamics in bio-molecules using accelerated molecular dynamics. Phys. Chem. Chem. Phys. 13, 20053-20065. doi: 10.1039/c1cp22100k .
122. Martinez, J. L., and Baquero, F. (2014). Emergence and spread of antibiotic resistance: setting a parameter space. Ups. J. Med. Sci. 119, 68-77. doi: 10.3109/03009734.2014.901444.
123. Maseda, H., Yoneyama, H., and Nakae, T. (2000). Assignment of the substrate-selective subunits of the MexEF-OprN multidrug effux pump of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 44, 658-664. doi: 10.1128/AAC.44.3.658-664.2000.
124. Mason, E. O. Jr., Wald, E. R., Bradley, J. S., Barson, W. J., and Kaplan, S. L. (2003). Macrolide resistance among middle ear isolates of Streptococcus pneumoniae observed at eight United States pediatric centers: prevalence of M and MLSB phenotypes. Pediatr. Infect. Dis. J. 22, 623-627. doi: 10.1097/01.inf.0000073124.06415.93.
125. Masuda, N., Gotoh, N., Ohya, S., and Nishino, T. (1996). Quantitative correlation between susceptibility and OprJ production in NfxB mutants of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 40, 909-913.
126. Masuda, N., and Ohya, S. (1992). Cross-resistance to meropenem, cephems, and quinolones in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 36, 1847-1851. doi: 10.1128/AAC.36.9.1847.
127. Masuda, N., Sakagawa, E., Ohya, S., Gotoh, N., and Nishino, T. (2001). Hypersusceptibility of the Pseudomonas aeruginosa nfxB mutant to beta-lactams due to reduced expression of the ampC beta-lactamase. Antimicrob. Agents Chemother. 45, 1284-1286. doi: 10.1128/AAC.45.4.1284-1286.2001.
128. Masuda, N., Sakagawa, E., Ohya, S., Gotoh, N., Tsujimoto, H., and Nishino, T. (2000a). Contribution of the MexX-MexY-oprM effux system to intrinsic resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 44, 2242-2246. doi: 10.1128/AAC.44.9.2242-2246.2000.
129. Masuda, N., Sakagawa, E., Ohya, S., Gotoh, N., Tsujimoto, H., and Nishino, T. (2000b). Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-oprM effux pumps in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 44, 3322-3327. doi: 10.1128/AAC.44.12.3322-3327.2000 .
130. Matsumoto, Y., Hayama, K., Sakakihara, S., Nishino, K., Noji, H., Iino, R., et al. (2011). Evaluation of multidrug effux pump inhibitors by a new method using microfluidic channels. PLoS ONE 6:e18547. doi: 10.1371/journal.pone.0018547.
131. May, A., Sieker, F., and Zacharias, M. (2008). How to efficiently include receptor flexibility during computational docking. Curr. Comput. Aided Drug Design 4, 143-153. doi: 10.2174/157340908784533265.
132. May, A., and Zacharias, M. (2008). Protein-ligand docking accounting for receptor side chain and global flexibility in normal modes: evaluation on kinase inhibitor cross docking. J. Med. Chem. 51, 3499-3506. doi: 10.1021/jm800071v.
133. Mazzariol, A., Cornaglia, G., and Nikaido, H. (2000). Contributions of the AmpC beta-lactamase and the AcrAB multidrug effux system in intrinsic resistance of Escherichia coli K-12 to beta-lactams. Antimicrob. Agents Chemother. 44, 1387-1390. doi: 10.1128/AAC.44.5.1387-1390.2000.
134. Mesaros, N., Glupczynski, Y., Avrain, L., Caceres, N. E., Tulkens, P. M., and Van Bambeke, F. (2007). A combined phenotypic and genotypic method for the detection of Mex effux pumps in Pseudomonas aeruginosa. J. Antimicrob Chemother. 59, 378-386. doi: 10.1093/jac/dkl504.
135. Middlemiss, J. K., and Poole, K. (2004). Differential impact of MexB mutations on substrate selectivity of the MexAB-OprM multidrug effux pump of Pseudomonas aeruginosa. J. Bacteriol. 186, 1258-1269. doi: 10.1128/JB.186.5.1258-1269.2004.
136. Mikolosko, J., Bobyk, K., Zgurskaya, H. I., and Ghosh, P. (2006). Conformational flexibility in the multidrug effux system protein AcrA. Structure 14, 577-587. doi: 10.1016/j.str.2005.11.015.
137. Mine, T., Morita, Y., Kataoka, A., Mizushima, T., and Tsuchiya, T. (1999). Expression in Escherichia coli of a new multidrug effux pump, MexXY, from Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 43, 415-417.
138. Misra, R., and Bavro, V. N. (2009). Assembly and transport mechanism of tripartite drug effux systems. Bba Proteins Proteom 1794, 817-825. doi: 10.1016/j.bbapap.2009.02.017 .
139. Misra, R, Morrison, K. D., Cho, H. J., and Khuu, T. (2015). Imortance of real-time assays to distinguish multidrug effux pump inhibiting and outer membrane destabilizing activities in Escherichia coli. J. Bacteriol. doi: 10.1128/JB.02456-4 [Epub ahead of print].
140. Morita, Y., Komori, Y., Mima, T., Kuroda, T., Mizushima, T., and Tsuchiya, T. (2001). Construction of a series of mutants lacking all of the four major mex operons for multidrug effux pumps or possessing each one of the operons from Pseudomonas aeruginosa PAO1: MexCD-OprJ is an inducible pump. FEMS Microbiol. Lett. 202, 139-143. doi: 10.1111/j.1574-6968.2001.tb10794.x.
141. Morita, Y., Murata, T., Mima, T., Shiota, S., Kuroda, T., Mizushima, T., et al. (2003). Induction of mexcd-oprJ operon for a multidrug effux pump by disinfectants in wild-type Pseudomonas aeruginosa PAO1. J. Antimicrob. Chemother. 51, 991-994. doi: 10.1093/jac/dkg173.
142. Morita, Y., Tomida, J., and Kawamura, Y. (2012). MexXY multidrug effux system of Pseudomonas aeruginosa. Front. Microbiol. 3:408. doi: 10.3389/fmicb.2012.00408.
143. Morita, Y., Tomida, J., and Kawamura, Y. (2014). Responses of Pseudomonas aeruginosa to antimicrobials. Front. Microbiol. 4:422. doi: 10.3389/fmicb.2013.00422.
144. Morita, Y., Tomida, J., and Kawamura, Y. (2015). Effux-mediated fluoroquinolone resistance in the multidrug-resistant Pseudomonas aeruginosa clinical isolate PA7: identification of a novel MexS variant involved in upregulation of the mexef-oprN multidrug effux operon. Front. Microbiol. 6:8. doi: 10.3389/fmicb.2015.00008.
145. Morris, J. D., Hewitt, J. L., Wolfe, L. G., Kamatkar, N. G., Chapman, S. M., Diener, J. M., et al. (2011). Imaging and analysis of Pseudomonas aeruginosa swarming and rhamnolipid production. Appl. Environ. Microbiol. 77, 8310-8317. doi: 10.1128/AEM.06644-11.
146. Mortimer, P. G., and Piddock, L. J. (1991). A comparison of methods used for measuring the accumulation of quinolones by Enterobacteriaceae, Pseudomonas aeruginosa and Staphylococcus aureus. J. Antimicrob. Chemother. 28, 639-653. doi: 10.1093/jac/28.5.639 .
147. Murakami, S. (2008). Multidrug effux transporter, AcrB-the pumping mechanism. Curr. Opin. Struct. Biol. 18, 459-465. doi: 10.1016/j.sbi.2008.06.007.
148. Murakami, S., Nakashima, R., Yamashita, E., Matsumoto, T., and Yamaguchi, A. (2006). Crystal structures of a multidrug transporter reveal a functionally rotating mechanism. Nature 443, 173-179. doi: 10.1038/nature05076.
149. Murakami, S., Nakashima, R., Yamashita, E., and Yamaguchi, A. (2002). Crystal structure of bacterial multidrug effux transporter AcrB. Nature 419, 587-593. doi: 10.1038/nature01050.
150. Murakami, S., Tamura, N., Saito, A., Hirata, T., and Yamaguchi, A. (2004). Extramembrane central pore of multidrug exporter AcrB in Escherichia coli plays an important role in drug transport. J. Biol. Chem. 279, 3743-3748. doi: 10.1074/jbc.M308893200.
151. Nagano, K., and Nikaido, H. (2009). Kinetic behavior of the major multidrug effux pump AcrB of Escherichia coli. Proc. Natl. Acad. Sci. U.S.A. 106, 5854-5858. doi: 10.1073/pnas.0901695106.
152. Nakashima, R., Sakurai, K., Yamasaki, S., Hayashi, K., Nagata, C., Hoshino, K., et al. (2013). Structural basis for the inhibition of bacterial multidrug exporters. Nature 500, 102-106. doi: 10.1038/nature12300.
153. Nakashima, R., Sakurai, K., Yamasaki, S., Nishino, K., and Yamaguchi, A. (2011). Structures of the multidrug exporter AcrB reveal a proximal multisite drug-binding pocket. Nature 480, 565-569. doi: 10.1038/nature10641.
154. Nakayama, K., Ishida, Y., Ohtsuka, M., Kawato, H., Yoshida, K., Yokomizo, Y., et al. (2003). MexAB-OprM-specific effux pump inhibitors in Pseudomonas aeruginosa. Part 1: discovery and early strategies for lead optimization. Bioorg. Med. Chem. Lett. 13, 4201-4204. doi: 10.1016/j.bmcl.2003.07.024.
155. Narita, S., Eda, S., Yoshihara, E., and Nakae, T. (2003). Linkage of the effux-pump expression level with substrate extrusion rate in the MexAB-OprM effux pump of Pseudomonas aeruginosa. Biochem. Biophys. Res. Commun. 308, 922-926. doi: 10.1016/S0006-291X(03)01512-2 .
156. Nikaido, H. (1996). Multidrug effux pumps of gram-negative bacteria. J. Bacteriol. 178, 5853-5859.
157. Nikaido, H. (2003). Molecular basis of bacterial outer membrane permeability revisited. Microbiol. Mol. Biol. Rev. 67, 593-656. doi: 10.1128/MMBR.67.4.593-656.2003.
158. Nikaido, H. (2011). Structure and mechanism of RND-type multidrug effux pumps. Adv. Enzymol. Relat. Areas Mol. Biol. 77, 1-60. doi: 10.1002/9780470920541.ch1.
159. Nikaido, H., Basina, M., Nguyen, V., and Rosenberg, E. Y. (1998). Multidrug effux pump AcrAB of Salmonella typhimurium excretes only those beta-lactam antibiotics containing lipophilic side chains. J. Bacteriol. 180, 4686-4692.
160. Nikaido, H., and Normark, S. (1987). Sensitivity of Escherichia coli to various beta-lactams is determined by the interplay of outer membrane permeability and degradation by periplasmic beta-lactamases: a quantitative predictive treatment. Mol. Microbiol. 1, 29-36. doi: 10.1111/j.1365-2958.1987.tb00523.x.
161. Nikaido, H., and Pages, J. M. (2012). Broad-specificity effux pumps and their role in multidrug resistance of Gram-negative bacteria. FEMS Microbiol. Rev. 36, 340-363. doi: 10.1111/j.1574-6976.2011.00290.x.
162. Nikaido, H., and Rosenberg, E. Y. (1983). Porin channels in Escherichia coli: studies with liposomes reconstituted from purified proteins. J. Bacteriol. 153, 241-252.
163. Nishino, K., Nikaido, E., and Yamaguchi, A. (2009). Regulation and physiological function of multidrug effux pumps in Escherichia coli and Salmonella. Biochim. Biophys. Acta 1794, 834-843. doi: 10.1016/j.bbapap.2009.02.002.
164. Nishino, K., and Yamaguchi, A. (2002). EvgA of the two-component signal transduction system modulates production of the yhiuv multidrug transporter in Escherichia coli. J. Bacteriol. 184, 2319-2323. doi: 10.1128/JB.184.8.2319-2323.2002 .
165. Ntsogo-Enguene, V. Y., Verchère, A., Phan, G., Broutin, I., and Picard, M. (2015). Catch me if you can: a biotinylated proteoliposome affinity assay for the investigation of assembly of the MexA-MexB-OprM effux pump from Pseudomonas aeruginosa. Front. Microbiol. 6:541. doi: 10.3389/fmicb.2015.00541.
166. Ocaktan, A., Yoneyama, H., and Nakae, T. (1997). Use of fluorescence probes to monitor function of the subunit proteins of the MexA-MexB-oprM drug extrusion machinery in Pseudomonas aeruginosa. J. Biol. Chem. 272, 21964-21969. doi: 10.1074/jbc.272.35.21964.
167. Ohene-Agyei, T., Lea, J. D., and Venter, H. (2012). Mutations in MexB that affect the effux of antibiotics with cytoplasmic targets. FEMS Microbiol. Lett. 333, 20-27. doi: 10.1111/j.1574-6968.2012.02594.x.
168. Olaitan, A. O., Morand, S., and Rolain, J. M. (2014). Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria. Front. Microbiol. 5:643. doi: 10.3389/fmicb.2014.00643.
169. Olivares, J., Bernardini, A., Garcia-Leon, G., Corona, F. M. B. S., and Martinez, J. L. (2013). The intrinsic resistome of bacterial pathogens. Front. Microbiol. 4:103. doi: 10.3389/fmicb.2013.00103.
170. Ong, C. T., Tessier, P. R., Li, C., Nightingale, C. H., and Nicolau, D. P. (2007). Comparative in vivo efficacy of meropenem, imipenem, and cefepime against Pseudomonas aeruginosa expressing MexA-MexB-OprM effux pumps. Diagn. Microbiol. Infect. Dis. 57, 153-161. doi: 10.1016/j.diagmicrobio.2006.06.014.
171. Ovchinnikov, V., and Karplus, M. (2012). Analysis and elimination of a bias in targeted molecular dynamics simulations of conformational transitions: application to calmodulin. J. Phys. Chem. B 116, 8584-8603. doi: 10.1021/jp212634z.
172. Page, M. G. (2012). The role of the outer membrane of Gram-negative bacteria in antibiotic resistance: Ajax' shield or Achilles' heel? Handb. Exp. Pharmacol. 211, 67-86. doi: 10.1007/978-3-642-28951-4_5.
173. Pages, J. M., Lavigne, J. P., Leflon-Guibout, V., Marcon, E., Bert, F., Noussair, L., et al. (2009). Effux pump, the masked side of beta-lactam resistance in Klebsiella pneumoniae clinical isolates. PLoS ONE 4:e4817. doi: 10.1371/journal.pone.0004817.
174. Pages, J. M., Masi, M., and Barbe, J. (2005). Inhibitors of effux pumps in Gram-negative bacteria. Trends Mol. Med. 11, 382-389. doi: 10.1016/j.molmed.2005.06.006.
175. Pai, H., Kim, J., Kim, J., Lee, J. H., Choe, K. W., and Gotoh, N. (2001). Carbapenem resistance mechanisms in Pseudomonas aeruginosa clinical isolates. Antimicrob. Agents Chemother. 45, 480-484. doi: 10.1128/AAC.45.2.480-484.2001.
176. Paixao, L., Rodrigues, L., Couto, I., Martins, M., Fernandes, P., De Carvalho, C. C., et al. (2009). Fluorometric determination of ethidium bromide effux kinetics in Escherichia coli. J. Biol. Eng. 3, 18. doi: 10.1186/1754-1611-3-18.
177. Parr, T. R. Jr., Moore, R. A., Moore, L. V., and Hancock, R. E. (1987). Role of porins in intrinsic antibiotic resistance of Pseudomonas cepacia. Antimicrob. Agents Chemother. 31, 121-123. doi: 10.1128/AAC.31.1.121.
178. Phan, G., Benabdelhak, H., Lascombe, M.-B., Benas, P., Rety, S., Picard, M., et al. (2010). Structural and dynamical Insights into the opening mechanism of P. aeruginosa OprM Channel. Structure 18, 507-517. doi: 10.1016/j.str.2010.01.018.
179. Phillips, J. L., and Gnanakaran, S. (2015). A Data-driven approach to modeling the tripartite structure of multidrug resistance effux pumps. Proteins 83, 43-65. doi: 10.1002/prot.24632.
180. Piddock, L. J. (2006). Clinically relevant chromosomally encoded multidrug resistance effux pumps in bacteria. Clin. Microbiol. Rev. 19, 382-402. doi: 10.1128/CMR.19.2.382-402.2006.
181. Piddock, L. J., Garvey, M. I., Rahman, M. M., and Gibbons, S. (2010). Natural and synthetic compounds such as trimethoprim behave as inhibitors of effux in Gram-negative bacteria. J. Antimicrob. Chemother. 65, 1215-1223. doi: 10.1093/jac/dkq079.
182. Pietras, Z., Bavro, V. N., Furnham, N., Pellegrini-Calace, M., Milner-White, E. J., and Luisi, B. F. (2008). Structure and mechanism of drug effux machinery in Gram negative bacteria. Curr. Drug Targets 9, 719-728. doi: 10.2174/138945008785747743.
183. Podnecky, N. L., Wuthiekanun, V., Peacock, S. J., and Schweizer, H. P. (2013). The BpeEF-OprC effux pump is responsible for widespread trimethoprim resistance in clinical and environmental Burkholderia pseudomallei isolates. Antimicrob. Agents Chemother. 57, 4381-4386. doi: 10.1128/AAC.00660-13.
184. Poole, K. (2000). Effux-mediated resistance to fluoroquinolones in gram-negative bacteria. Antimicrob. Agents Chemother. 44, 2233-2241. doi: 10.1128/AAC.44.9.2233-2241.2000.
185. Poole, K. (2004). Effux-mediated multiresistance in Gram-negative bacteria. Clin. Microbiol. Infect. 10, 12-26. doi: 10.1111/j.1469-0691.2004.00763.x.
186. Poole, K. (2005). Effux-mediated antimicrobial resistance. J. Antimicrob. Chemother. 56, 20-51. doi: 10.1093/jac/dki171.
187. Poole, K. (2011). Pseudomonas aeruginosa: resistance to the max. Front. Microbiol. 2:65. doi: 10.3389/fmicb.2011.00065.
188. Poole, K. (2013). "Pseudomonas aeruginosa effux pumps," in: Microbial Effux Pumps, eds E. W. Yu, Q. Zhang, and M. H. Brown (Norfolk: Caister Academic Press).
189. Poole, K. (2014). Stress responses as determinants of antimicrobial resistance in Pseudomonas aeruginosa: multidrug effux and more. Can. J. Microbiol. 60, 783-791. doi: 10.1139/cjm-2014-0666.
190. Potron, A., Poirel, L., and Nordmann, P. (2015). Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: mechanisms and epidemiology. Int. J. Antimicrob. Agents 45, 568-585. doi: 10.1016/j.ijantimicag.2015.03.001.
191. Pournaras, S., Maniati, M., Spanakis, N., Ikonomidis, A., Tassios, P. T., Tsakris, A., et al. (2005). Spread of effux pump-overexpressing, non-metallo-beta-lactamase-producing, meropenem-resistant but ceftazidime-susceptible Pseudomonas aeruginosa in a region with blaVIM endemicity. J. Antimicrob. Chemother. 56, 761-764. doi: 10.1093/jac/dki296 .
192. Pumbwe, L., and Piddock, L. J. (2000). Two effux systems expressed simultaneously in multidrug-resistant Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 44, 2861-2864. doi: 10.1128/AAC.44.10.2861-2864.2000.
193. Rampersad, S. N. (2012). Multiple applications of Alamar Blue as an indicator of metabolic function and cellular health in cell viability bioassays. Sensors (Basel) 12, 12347-12360. doi: 10.3390/s120912347.
194. Raunest, M., and Kandt, C. (2012). Locked on one side only: ground state dynamics of the outer membrane effux duct TolC. Biochemistry 51, 1719-1729. doi: 10.1021/bi201814s.
195. Renau, T. E., Leger, R., Yen, R., She, M. W., Flamme, E. M., Sangalang, J., et al. (2002). Peptidomimetics of effux pump inhibitors potentiate the activity of levofloxacin in Pseudomonas aeruginosa. Bioorg. Med. Chem. Lett. 12, 763-766. doi: 10.1016/S0960-894X(02)00006-9.
196. Renau, T. E., and Lemoine, R. C. (2001). Effux pump ihibitors to address bacterial and fungal resistance. Drugs Fut. 26, 1171-1178. doi: 10.1358/dof.2001.026.12.644122.
197. Richmond, G. E., Chua, K. L., and Piddock, L. J. (2013). Effux in Acinetobacter baumannii can be determined by measuring accumulation of H33342 (bis-benzamide). J. Antimicrob. Chemother. 68, 1594-1600. doi: 10.1093/jac/dkt052.
198. Riera, E., Cabot, G., Mulet, X., Garcia-Castillo, M., Del Campo, R., Juan, C., et al. (2011). Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem. J. Antimicrob. Chemother. 66, 2022-2027. doi: 10.1093/jac/dkr232.
199. Riou, M., Carbonnelle, S., Avrain, L., Mesaros, N., Pirnay, J. P., Bilocq, F., et al. (2010). In vivo development of antimicrobial resistance in Pseudomonas aeruginosa strains isolated from the lower respiratory tract of Intensive Care Unit patients with nosocomial pneumonia and receiving antipseudomonal therapy. Int. J. Antimicrob. Agents. 36, 513-522. doi: 10.1016/j.ijantimicag.2010.08.005.
200. Rosen, B. P., and Kashket, E. R. (1978). "Energetics of active transport," in: Bacterial Transport, ed. B. P. Rosen (New York: Marcel Dekker Inc.).
201. Ruggerone, P., Murakami, S., Pos, K. M., and Vargiu, A. V. (2013a). Rnd effux pumps: structural information translated into function and inhibition mechanisms. Curr. Top. Med. Chem. 13, 3079-3100. doi: 10.2174/15680266113136660220.
202. Ruggerone, P., Vargiu, A. V., Collu, F., Fischer, N., and Kandt, C. (2013b). Molecular dynamics computer simulations of multidrug RND effux pumps. Computat. Struct. Biotechnol. J. 5:e201302008. doi: 10.5936/csbj.201302008.
203. Russo-Marie, F., Roederer, M., Sager, B., Herzenberg, L. A., and Kaiser, D. (1993). Beta-galactosidase activity in single differentiating bacterial cells. Proc. Natl. Acad. Sci. U.S.A. 90, 8194-8198. doi: 10.1073/pnas.90.17.8194.
204. Ruzin, A., Keeney, D., and Bradford, P. A. (2005). AcrAB effux pump plays a role in decreased susceptibility to tigecycline in Morganella morganii. Antimicrob. Agents Chemother. 49, 791-793. doi: 10.1128/AAC.49.2.791-793.2005.
205. Schlitter, J., Engels, M., Kruger, P., Jacoby, E., and Wollmer, A. (1993). Targeted molecular-dynamics simulation of conformational change-application to the T[-]R transition in insulin. Mol. Simulat. 10, 291-308. doi: 10.1080/08927029308022170.
206. Schulz, G. E. (1993). Bacterial porins: structure and function. Curr. Opin. Cell Biol. 5, 701-707. doi: 10.1016/0955-0674(93)90143-E.
207. Schulz, R., and Kleinekathöfer, U. (2009). Transitions between closed and open conformations of TolC: the effects of ions in simulations. Biophys. J. 96, 3116-3125. doi: 10.1016/j.bpj.2009.01.021.
208. Schulz, R., Vargiu, A. V., Collu, F., Kleinekathoefer, U., and Ruggerone, P. (2010). Functional rotation of the transporter AcrB: insights into drug extrusion from simulations. PLoS Comput. Biol. 6:e1000806. doi: 10.1371/journal.pcbi.1000806.
209. Schulz, R., Vargiu, A. V., Ruggerone, P., and Kleinekathöfer, U. (2011). Role of water during the extrusion of substrates by the effux transporter AcrB. J. Phys. Chem. B 115, 8278-8287. doi: 10.1021/jp200996x .
210. Schulz, R., Vargiu, A. V., Ruggerone, P., and Kleinekathöfer, U. (2015). Computational study of correlated domain motions in the acrb effux transporter. BioMed. Res. Int. 12:487298 doi: 10.1155/2015/487298.
211. Schumacher, A., Trittler, R., Bohnert, J. A., Kummerer, K., Pages, J. M., and Kern, W. V. (2007). Intracellular accumulation of linezolid in Escherichia coli, citrobacter freundii and enterobacter aerogenes: role of enhanced effux pump activity and inactivation. J. Antimicrob. Chemother. 59, 1261-1264. doi: 10.1093/jac/dkl380.
212. Schweizer, H. P. (2003). Effux as a mechanism of resistance to antimicrobials in Pseudomonas aeruginosa and related bacteria: unanswered questions. Genet. Mol. Res. 2, 48-62.
213. Sedgwick, E. G., and Bragg, P. D. (1996). The role of effux systems and the cell envelope in fluorescence changes of the lipophilic cation 2-(4-dimethylaminostyryl)-1-ethylpyridinium in Escherichia coli. Biochim. Biophys. Acta 1278, 205-212. doi: 10.1016/0005-2736(95)00228-6.
214. Seeger, M. A., Schiefner, A., Eicher, T., Verrey, F., Diederichs, K., and Pos, K. M. (2006). Structural asymmetry of AcrB trimer suggests a peristaltic pump mechanism. Science 313, 1295-1298. doi: 10.1126/science.1131542.
215. Sekiya, H., Mima, T., Morita, Y., Kuroda, T., Mizushima, T., and Tsuchiya, T. (2003). Functional cloning and characterization of a multidrug effux pump, mexHI-opmD, from a Pseudomonas aeruginosa mutant. Antimicrob. Agents Chemother. 47, 2990-2992. doi: 10.1128/AAC.47.9.2990-2992.2003.
216. Senn, H. M., and Thiel, W. (2009). QM/MM methods for biomolecular systems. Angew. Chem. Int. Ed. Engl. 48, 1198-1229. doi: 10.1002/anie.200802019.
217. Sennhauser, G., Amstutz, P., Briand, C., Storchenegger, O., and Grutter, M. G. (2007). Drug export pathway of multidrug exporter AcrB revealed by Darpin inhibitors. PLoS Biol. 5:e7. doi: 10.1371/journal.pbio.0050007.
218. Sennhauser, G., Bukowska, M. A., Briand, C., and Grutter, M. G. (2009). Crystal structure of the multidrug exporter MexB from Pseudomonas aeruginosa. J. Mol. Biol. 389, 134-145. doi: 10.1016/j.jmb.2009.04.001 .
219. Sgrignani, J., and Magistrato, A. (2013). First-principles modeling of biological systems and structure-based drug-design. Curr. Comput. Aided Drug Des. 9, 15-34.
220. Shapiro, H. M. (2000). Membrane potential estimation by flow cytometry. Methods 21, 271-279. doi: 10.1006/meth.2000.1007.
221. Steinbrecher, T., and Elstner, M. (2013). QM and QM/MM simulations of proteins. Methods Mol. Biol. 924, 91-124. doi: 10.1007/978-1-62703-017-5_5.
222. Steinbrecher, T., Prock, S., Reichert, J., Wadhwani, P., Zimpfer, B., Bürck, J., et al. (2012). Peptide-lipid interactions of the stress-response peptide TisB that induces bacterial persistence. Biophys. J. 103, 1460-1469. doi: 10.1016/j.bpj.2012.07.060.
223. Sterpone, F., Ceccarelli, M., and Marchi, M. (2001). Dynamics of hydration in hen egg white lysozyme. J. Mol. Biol. 311, 409-419. doi: 10.1006/jmbi.2001.4860.
224. Su, C. C., and Yu, E. W. (2007). Ligand-transporter interaction in the AcrB multidrug effux pump determined by fluorescence polarization assay. FEBS Lett. 581, 4972-4976. doi: 10.1016/j.febslet.2007.09.035.
225. Sugawara, E., Nagano, K., and Nikaido, H. (2010). Factors affecting the folding of Pseudomonas aeruginosa OprF porin into the one-domain open conformer. MBio 1:e00228-10. doi: 10.1128/mBio.00228-10.
226. Sugawara, E., Nestorovich, E. M., Bezrukov, S. M., and Nikaido, H. (2006). Pseudomonas aeruginosa porin OprF exists in two different conformations. J. Biol. Chem. 281, 16220-16229. doi: 10.1074/jbc.M600680200.
227. Sun, J., Deng, Z., and Yan, A. (2014). Bacterial multidrug effux pumps: mechanisms, physiology and pharmacological exploitations. Biochem. Biophys. Res. Commun. 453, 254-267. doi: 10.1016/j.bbrc.2014.05.090.
228. Symmons, M., Bokma, E., Koronakis, E., Hughes, C., and Koronakis, V. (2009). The assembled structure of a complete tripartite bacterial multidrug effux pump. Proc. Natl. Acad. Sci. U.S.A. 106, 7173-7178. doi: 10.1073/pnas.0900693106 .
229. Takatsuka, Y., Chen, C., and Nikaido, H. (2010). Mechanism of recognition of compounds of diverse structures by the multidrug effux pump AcrB of Escherichia coli. Proc. Natl. Acad. Sci. U.S.A. 107, 6559-6565. doi: 10.1073/pnas.1001460107.
230. Thanassi, D. G., Cheng, L. W., and Nikaido, H. (1997). Active effux of bile salts by Escherichia coli. J. Bacteriol. 179, 2512-2518.
231. Tikhonova, E. B., Wang, Q., and Zgurskaya, H. I. (2002). Chimeric analysis of the multicomponent multidrug effux transporters from gram-negative bacteria. J. Bacteriol. 184, 6499-6507. doi: 10.1128/JB.184.23.6499-6507.2002.
232. Tikhonova, E. B., Yamada, Y., and Zgurskaya, H. I. (2011). Sequential mechanism of assembly of multidrug effux pump AcrAB-TolC. Chem. Biol. 18, 454-463. doi: 10.1016/j.chembiol.2011.02.011.
233. Trepout, S., Taveau, J. C., Benabdelhak, H., Granier, T., Ducruix, A., Frangakis, A. S., et al. (2010). Structure of reconstituted bacterial membrane effux pump by cryo-electron tomography. Biochim. Biophys. Acta 1798, 1953-1960. doi: 10.1016/j.bbamem.2010.06.019.
234. Vaara, M. (1992). Agents that increase the permeability of the outer membrane. Microbiol. Rev. 56, 395-411.
235. Vaccaro, L., Koronakis, V., and Sansom, M. S. P. (2006). Flexibility in a drug transport accessory protein: molecular dynamics simulations of MexA. Biophys. J. 91, 558-564. doi: 10.1529/biophysj.105.080010.
236. Vaccaro, L., Scott, K. A., and Sansom, M. S. P. (2008). Gating at both ends and breathing in the middle: conformational dynamics of TolC. Biophys. J. 95, 5681-5691. doi: 10.1529/biophysj.108.136028.
237. Van Bambeke, F., Pagès, J.-M., and Lee, V. J. (2010). Inhibitors of bacterial effux pumps as adjuvant in antibacterial therapy and diagnostic tools for detection of resistance by effux. Front. Anti Infect. Drug Discov. 1: 138-175.
238. van den Berg van Saparoea, H. B., Lubelski, J., Van Merkerk, R., Mazurkiewicz, P. S., and Driessen, A. J. (2005). Proton motive force-dependent Hoechst 33342 transport by the ABC transporter LmrA of Lactococcus lactis. Biochemistry 44, 16931-16938. doi: 10.1021/bi051497y .
239. Vargiu, A. V., Collu, F., Schulz, R., Pos, K. M., Zacharias, M., Kleinekathöfer, U., et al. (2011). Effect of the F610A mutation on substrate extrusion in the AcrB transporter: explanation and rationale by molecular dynamics simulations. J. Am. Chem. Soc. 133, 10704-10707. doi: 10.1021/ja202666x.
240. Vargiu, A. V., and Nikaido, H. (2012). Multidrug binding properties of the AcrB effux pump characterized by molecular dynamics simulations. Proc. Natl. Acad. Sci. U.S.A. 109, 20637-20642. doi: 10.1073/pnas.1218348109.
241. Vargiu, A. V., Ruggerone, P., Opperman, T. J., Nguyen, S. T., and Nikaido, H. (2014). Molecular mechanism of Mbx2319 inhibition of Escherichia coli AcrB multidrug effux pump and comparison with other inhibitors. Antimicrob. Agents Chemother. 58, 6224-6234. doi: 10.1128/AAC.03283-14.
242. Verchère, A., Dezi, M., Adrien, V., Broutin, I., and Picard, M. (2015). In vitro transport activity of the fully assembled MexAB-OprM effux pump from Pseudomonas aeruginosa. Nat. Commun. 6, 6890. doi: 10.1038/ncomms7890.
243. Verchère, A., Dezi, M., Broutin, I., and Picard, M. (2014). In vitro investigation of the MexAB effux pump from Pseudomonas aeruginosa. J. Vis. Exp. 84:e50894. doi: 10.3791/50894.
244. Vidal-Aroca, F., Meng, A., Minz, T., Page, M. G., and Dreier, J. (2009). Use of resazurin to detect mefloquine as an effux-pump inhibitor in Pseudomonas aeruginosa and Escherichia coli. J. Microbiol. Methods 79, 232-237. doi: 10.1016/j.mimet.2009.09.021.
245. Visalli, M. A., Murphy, E., Projan, S. J., and Bradford, P. A. (2003). AcrAB multidrug effux pump is associated with reduced levels of susceptibility to tigecycline (GAR-936) in Proteus mirabilis. Antimicrob. Agents Chemother. 47, 665-669. doi: 10.1128/AAC.47.2.665-669.2003.
246. Viveiros, M., Martins, A., Paixao, L., Rodrigues, L., Martins, M., Couto, I., et al. (2008). Demonstration of intrinsic effux activity of Escherichia coli K-12 AG100 by an automated ethidium bromide method. Int. J. Antimicrob. Agents 31, 458-462. doi: 10.1016/j.ijantimicag.2007.12.015.
247. Walmsley, A. R., Martin, G. E., and Henderson, P. J. (1994). 8-Anilino-1-naphthalenesulfonate is a fluorescent probe of conformational changes in the D-galactose-H+ symport protein of Escherichia coli. J. Biol. Chem. 269, 17009-17019.
248. Walsh, F., and Amyes, S. G. (2007). Carbapenem resistance in clinical isolates of Pseudomonas aeruginosa. J. Chemother. 19, 376-381. doi: 10.1179/joc.2007.19.4.376.
249. Wang, B., Weng, J., Fan, K., and Wang, W. (2012). Interdomain flexibility and pH-Induced conformational changes of AcrA revealed by molecular dynamics simulations. J. Phys. Chem. B 116, 3411-3420. doi: 10.1021/jp212221v.
250. Watkins, W. J., Landaverry, Y., Leger, R., Litman, R., Renau, T. E., Williams, N., et al. (2003). The relationship between physicochemical properties, in vitro activity and pharmacokinetic profiles of analogues of diamine-containing effux pump inhibitors. Bioorg. Med. Chem. Lett. 13, 4241-4244. doi: 10.1016/j.bmcl.2003.07.030.
251. Webber, M. A., and Piddock, L. J. (2003). The importance of effux pumps in bacterial antibiotic resistance. J. Antimicrob. Chemother. 51, 9-11. doi: 10.1093/jac/dkg050.
252. Wehmeier, C., Schuster, S., Fahnrich, E., Kern, W. V., and Bohnert, J. A. (2009). Site-directed mutagenesis reveals amino acid residues in the Escherichia coli RND effux pump AcrB that confer macrolide resistance. Antimicrob. Agents Chemother. 53, 329-330. doi: 10.1128/AAC.00921-08.
253. Welch, A., Awah, C. U., Jing, S., Van Veen, H. W., and Venter, H. (2010). Promiscuous partnering and independent activity of MexB, the multidrug transporter protein from Pseudomonas aeruginosa. Biochem. J. 430, 355-364. doi: 10.1042/BJ20091860.
254. Xu, X. H. N., Brownlow, W., Huang, S., and Chen, J. (2003). Single-molecule detection of effux pump machinery in Pseudomonas aeruginosa. Biochem. Biophys. Res. Commun. 305, 79-86. doi: 10.1016/S0006-291X(03)00692-2.
255. Xu, Y., Lee, M., Moeller, A., Song, S., Yoon, B.-Y., Kim, H.-M., et al. (2011). Funnel-like hexameric assembly of the periplasmic adapter protein in the tripartite multidrug effux pump in gram-negative bacteria. J. Biol. Chem. 286, 17910-17920. doi: 10.1074/jbc.M111.238535 .
256. Yamaguchi, A., Nakashima, R., and Sakurai, K. (2015). Structural basis of RND-type multidrug exporters. Front. Microbiol. 6:327. doi: 10.3389/fmicb.2015.00327.
257. Yamaguchi, A., Udagawa, T., and Sawai, T. (1990). Transport of divalent cations with tetracycline as mediated by the transposon Tn10-encoded tetracycline resistance protein. J. Biol. Chem. 265, 4809-4813.
258. Yang, N. C., and Hu, M. L. (2004). A fluorimetric method using fluorescein di-beta-D-galactopyranoside for quantifying the senescence-associated beta-galactosidase activity in human foreskin fibroblast Hs68 cells. Anal. Biochem. 325, 337-343. doi: 10.1016/j.ab.2003.11.012.
259. Yao, X.-Q., Kimura, N., Murakami, S., and Takada, S. (2013). Drug uptake pathways of multidrug transporter AcrB studied by molecular simulations and site-directed mutagenesis experiments. J. Am. Chem. Soc. 135, 7474-7485. doi: 10.1021/ja310548h.
260. Yoshida, K., Nakayama, K., Ohtsuka, M., Kuru, N., Yokomizo, Y., Sakamoto, A., et al. (2007). MexAB-OprM specific effux pump inhibitors in Pseudomonas aeruginosa. Part 7: highly soluble and in vivo active quaternary ammonium analogue D13-9001, a potential preclinical candidate. Bioorg. Med. Chem. 15, 7087-7097. doi: 10.1016/j.bmc.2007.07.039.
261. Yoshimura, F., and Nikaido, H. (1982). Permeability of Pseudomonas aeruginosa outer membrane to hydrophilic solutes. J. Bacteriol. 152, 636-642.
262. Zechini, B., and Versace, I. (2009). Inhibitors of multidrug resistant effux systems in bacteria. Recent Patents Anti Infect. Drug Discov. 4, 37-50. doi: 10.2174/157489109787236256.
263. Zgurskaya, H. I., and Nikaido, H. (1999). Bypassing the periplasm: reconstitution of the AcrAB multidrug effux pump of Escherichia coli. Proc. Natl. Acad. Sci. U.S.A. 96, 7190-7195. doi: 10.1073/pnas.96.13.7190.
264. Zhanel, G. G., Decorby, M., Adam, H., Mulvey, M. R., Mccracken, M., Lagace-Wiens, P., et al. (2010). Prevalence of antimicrobial-resistant pathogens in Canadian hospitals: results of the Canadian Ward Surveillance Study (Canward 2008). Antimicrob. Agents Chemother. 54, 4684-4693. doi: 10.1128/AAC.00469-10 .
265. Zhou, T., Huang, D., and Caflisch, A. (2010). Quantum mechanical methods for drug design. Curr. Top. Med. Chem. 10, 33-45. doi: 10.2174/156802610790232242.